Sumitomo Dainippon has appointed Hiroshi Nomura, currently executive vice president, as the firm’s new president and chief executive, effective from 1 April 2018.
Mr Nomura is replacing Masayo Tada, who will take up the position of chairman.
Mr Nomura joined the firm in 2003, becoming senior director of finance & accounting in 2005, and taking up successive roles of increasing seniority thereafter.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze